Clinical trials
Recruiting Colorectal Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 20 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 6 |
| Bristol-Myers Squibb | 3 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 3 |
| GlaxoSmithKline | 3 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Incyte Corporation | 2 |
| Janssen Research & Development, LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 60 |
| Breast Neoplasms | 13 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Neoplasms | 9 |
| Lung Neoplasms | 7 |
| Melanoma | 7 |
| Pancreatic Neoplasms | 7 |
| Stomach Neoplasms | 7 |
| Endometrial Neoplasms | 6 |
| Neoplasm Metastasis | 6 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.